Date published: 2026-2-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

KLK14 Activators

KLK14 Activators encompasses a group of compounds and substances that are known to modulate or stimulate the activity of the kallikrein-related peptidase 14 (KLK14) enzyme. KLK14, a member of the KLK family, is a serine protease with diverse physiological roles, including involvement in skin biology and tissue remodeling, and its activation or regulation is of interest in various research contexts. These activators interact with KLK14 through a range of mechanisms, either directly or indirectly, and are utilized primarily in experimental and investigative settings to study the enzyme's functions and regulatory pathways.

KLK14 activators can be categorized into two broad groups: direct and indirect activators. Direct activators are those that directly bind to and modify the enzymatic activity of KLK14, promoting its proteolytic functions. These may include small molecules or peptides designed to enhance the catalytic efficiency of the enzyme. On the other hand, indirect activators influence KLK14 activity by targeting upstream or downstream components of signaling pathways that converge on the enzyme. These compounds can alter the expression or post-translational modifications of KLK14, ultimately impacting its function. In both cases, the aim is to gain a better understanding of KLK14's role in various biological processes, such as skin desquamation and potential contributions to disease states, by manipulating its activity. The study of KLK14 activators contributes to the broader field of enzymology and protease biology, shedding light on the intricate regulatory networks that govern this protease's function in different physiological and pathological contexts.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

A retinoid compound that activates KLK14 expression by modulating gene regulatory mechanisms and cellular differentiation.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A protein kinase inhibitor that indirectly triggers KLK14 activation through modulation of downstream signaling pathways.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase inhibitor that indirectly initiates KLK14 activation by modifying chromatin structure and gene activation mechanisms.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that can indirectly activate KLK14 expression by influencing epigenetic activation mechanisms, including DNA methylation.

Aprotinin

9087-70-1sc-3595
sc-3595A
sc-3595B
10 mg
100 mg
1 g
$112.00
$408.00
$3000.00
51
(2)

A protease inhibitor that indirectly modulates serine protease activity, potentially activating KLK14 through the enzymatic mechanisms it targets, including serine proteases like KLK14.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

An activator of protein kinase C (PKC) that indirectly initiates KLK14 activation by interacting with PKC signaling pathways and related cellular processes.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

A histone deacetylase inhibitor that indirectly activates KLK14 by modifying chromatin structure and gene activation mechanisms, potentially impacting KLK14 expression.